Dharni Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 13-12-2024
- Paid Up Capital ₹ 1.00 M
as on 13-12-2024
- Company Age 29 Year, 9 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.70 M
as on 13-12-2024
- Revenue %
(FY 2021)
- Profit 30.91%
(FY 2021)
- Ebitda 30.91%
(FY 2021)
- Net Worth -4.76%
(FY 2021)
- Total Assets -0.17%
(FY 2021)
About Dharni Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.70 M.
Kunj Rungta and Rash Rungta serve as directors at the Company.
- CIN/LLPIN
U24232RJ1996PTC011445
- Company No.
011445
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 1996
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dharni Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rash Rungta  | Director | 28-Dec-2011 | Current |
| Kunj Rungta | Director | 19-Jan-1996 | Current |
Financial Performance of Dharni Pharma.
Dharni Pharma Pvt Ltd, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 30.91% increase in profit. The company's net worth dipped by a decrease of 4.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dharni Pharma?
In 2021, Dharni Pharma had a promoter holding of 67.40% and a public holding of 32.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹9.70 M
₹0
Charges Breakdown by Lending Institutions
- I.D.B.I. Bank Ltd. : 0.50 Cr
- Icici Bank Limited : 0.38 Cr
- Dena Bank : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Sep 2005 | Icici Bank Limited | ₹3.80 M | Open |
| 08 Oct 2002 | Dena Bank | ₹0.90 M | Open |
| 08 Dec 1999 | I.D.B.I. Bank Ltd. | ₹5.00 M | Open |
How Many Employees Work at Dharni Pharma?
Unlock and access historical data on people associated with Dharni Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dharni Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dharni Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
